Evidence map›Paper›PMID 29403442›Full record

ArticleFrontiers in microbiology2017

Maya Yamashita, Ken Ukibe, Yumi Matsubara, Tomohiro Hosoya, Fumihiko Sakai, Shigeyuki Kon, Yasunobu Arima, Masaaki Murakami, Hisako Nakagawa, Tadaaki Miyazaki

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Detection of galanin receptors in the spinal cord in experimental autoimmune encephalomyelitis.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2023
    Article
  7. Updates on the Role of Probiotics against Different Health Issues: Focus onInternational journal of molecular sciences · 2022
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Targeting the gut to treat multiple sclerosis.The Journal of clinical investigation · 2021
    Review
  16. Article
  17. Review
  18. Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.Advances in experimental medicine and biology · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Maya YamashitaMilk Science Research Institute, Megmilk Snow Brand Co., Ltd., Saitama, Japan.
Ken UkibeMilk Science Research Institute, Megmilk Snow Brand Co., Ltd., Saitama, Japan.
Yumi MatsubaraDepartment of Probiotics Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
Tomohiro HosoyaMilk Science Research Institute, Megmilk Snow Brand Co., Ltd., Saitama, Japan.
Fumihiko SakaiMilk Science Research Institute, Megmilk Snow Brand Co., Ltd., Saitama, Japan.
Shigeyuki KonDepartment of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Fukuyama, Japan.
Yasunobu ArimaDepartment of Molecular Neuroimmunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
Masaaki MurakamiDepartment of Molecular Neuroimmunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
Hisako NakagawaDepartment of Probiotics Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
Tadaaki MiyazakiDepartment of Probiotics Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
Hokkaido University · JPMegmilk Snow Brand (Japan) · JPFukuyama University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently reported that

Indexed as

experimental autoimmune encephalomyelitisinterleukin-6Lactobacillus helveticus SBT2171multiple sclerosisTh17 cells

Identifiers

PMID29403442
PMCPMC5786557
OpenAlexW2781924795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.